Earnings Call · Q3 FY2025·2025-11-10

Q3 25EPS +14.75%·Rev n/aQ2 25EPS +10.81%·Rev n/aQ1 25EPS +19.39%·Rev n/aQ4 24EPS +9.26%·Rev n/a⚠ consensus missing

Mineralys Therapeutics, Inc. MLYS

Daniel Ferry — Investor Relations or IR Host

Jon Congleton — Chief Executive Officer

Adam Levy — Chief Financial Officer

+5.9%1d on move date+5.6% vs SPY3d−0.5%5d−0.5%

Research tier

Behavioral profile computed for 3 speakers on this call.

Sign in to view the Behavioral Lean, the Behavioral Deviation Score, the speaker decomposition, and the novel forward-guidance phrases flagged on this call — each scored against the speaker's own prior-call baseline.

Behavioral data on every earnings call

Per-speaker language deviation, scored against each executive's own history. Explore more MLYS calls or request research access.

More MLYS calls Browse calls Request research access